Overview

At enGene we aim to make genetic medicine mainstream by developing non-viral therapeutics that are delivered directly to mucosal tissues and other organs. Our mission is to deliver innovative, non-viral medicines to improve the quality of life for people with urological cancers—starting with non-muscle invasive bladder cancer (NMIBC) and expanding beyond. We are developing innovative solutions with the goal of reducing treatment burden and improving patient outcomes.